Exchange: OTC·Updated 05:10 PM EDT

GTBIF News

News
all
press releases
Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?
Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.
Zacks
More News
Can Green Thumb Industries Inc. (GTBIF) Run Higher on Rising Earnings Estimates?
Green Thumb Industries Inc. (GTBIF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
Wall Street Analysts Think Green Thumb Industries Inc. (GTBIF) Could Surge 104.86%: Read This Before Placing a Bet
The mean of analysts' price targets for Green Thumb Industries Inc. (GTBIF) points to a 104.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
Should You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release?
Green Thumb tops Q2 earnings and sales estimates, but can regulatory catalysts, buybacks and expansion plans outweigh pricing pressure and fierce competition?
Zacks
Should You Buy, Hold or Sell SNDL Stock Post Q4 Earnings Release?
SNDL sinks after weak Q2 2026 earnings, but can cost cuts and U.S. expansion through Parallel offset ongoing cannabis and liquor headwinds?
Zacks
Is JAZZ Still the Best Cannabis Stock After Federal Rescheduling?
Jazz Pharmaceuticals pairs its FDA-approved CBD blockbuster with a diversified drug portfolio, offering medical cannabis exposure despite ongoing pipeline risks.
Zacks
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.
Zacks
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.
Zacks
MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?
The cannabis ETF has surged 104% over the past year, outperforming both the North American Marijuana Index and the S&P 500.
Stocktwits
Verano Advances U.S. Exchange Uplisting Plans: Time to Invest?
VRNO's reverse split and prior U.S. redomestication support potential exchange uplisting plans as the company expands stores and product offerings.
Zacks

Advertisement|Remove ads.